Korean J Gastroenterol.  2022 Sep;80(3):154-157. 10.4166/kjg.2022.054.

Hyponatremic Seizure after Ingestion of an Oral Sulfate Tablet for Bowel Preparation for Colonoscopy

• Hong SH
• Lee DS
• Kim JW
• Lee KL
• Kang HW
• Kim SH

• KMID: 2533319
• DOI: http://doi.org/10.4166/kjg.2022.054

Abstract

The oral sulfate tablet (OST), commercially available as Orafang ^® (Pharmbio Korea Co., Seoul, Korea) in Korea, is being used increasingly because of its bowel-cleansing efficacy, safety, and tolerability in adults undergoing colonoscopy. Other bowel cleansing agents, such as polyethylene glycol and sodium picosulfate/magnesium citrate, can cause plasma volume depletion and electrolyte disturbances, such as hyponatremia. On the other hand, the OST has never been reported to cause hyponatremia in Korea. To our knowledge, the authors experienced the first case of hyponatremic seizure in an 81-year-old woman to whom an OST was administered for bowel preparation before a colonoscopy. After ingesting the OST, she presented with seizure, confusion, and dyspnea. Upon arrival, her serum sodium level was 120 mEq/L, and the urine osmolality and sodium levels were 449 mOsm/kg and 253 mOsm/kg, respectively; chest imaging suggested pulmonary edema. The associated symptoms disappeared following treatment with an intravenous injection of normal saline and 3% NaCl to normalize the sodium level. This case shows that the OST can cause hyponatremia and other severe complications related to hyponatremia.

Keyword

Bowel preparation; Colonoscopy; Oral sulfate tablet; Seizures; Hyponatremia

Figure

• 

  Fig. 1 Chest computed tomography scan showing mild diffuse ground-glass opacity in both lungs.

Reference

1. Nishihara R, Wu K, Lochhead P, et al. 2013; Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 369:1095–1105. DOI: 10.1056/NEJMoa1301969. PMID: 24047059. PMCID: PMC3840160.

2. Brenner H, Stock C, Hoffmeister M. 2014; Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ. 348:g2467. DOI: 10.1136/bmj.g2467. PMID: 24922745. PMCID: PMC3980789.

3. Leitao K, Grimstad T, Bretthauer M, et al. 2014; Polyethylene glycol vs sodium picosulfate/magnesium citrate for colonoscopy preparation. Endosc Int Open. 2:E230–E234. DOI: 10.1055/s-0034-1377520. PMID: 26135098. PMCID: PMC4423298.

4. Na JE, Kim ER. 2021; How to choose the optimal bowel preparation regimen for colonoscopy. Ewha Med J. 44:122–132. DOI: 10.12771/emj.2021.44.4.122.

5. Yang HJ, Park DI, Park SK, et al. 2020; Novel sulfate tablet PBK-1701TC versus oral sulfate solution for colon cleansing: a randomized phase 3 trial. J Gastroenterol Hepatol. 35:29–36. DOI: 10.1111/jgh.14826. PMID: 31396995.

6. Weir MA, Fleet JL, Vinden C, et al. 2014; Hyponatremia and sodium picosulfate bowel preparations in older adults. Am J Gastroenterol. 109:686–694. DOI: 10.1038/ajg.2014.20. PMID: 24589671.

7. Cho YS, Nam KM, Park JH, Byun SH, Ryu JS, Kim HJ. 2014; Acute hyponatremia with seizure and mental change after oral sodium picosulfate/magnesium citrate bowel preparation. Ann Coloproctol. 30:290–293. DOI: 10.3393/ac.2014.30.6.290. PMID: 25580417. PMCID: PMC4286777.

8. Marín Gabriel JC, Rodríguez Muñoz S, de la Cruz Bértolo J, et al. 2003; Electrolytic disturbances and colonoscopy: bowel lavage solutions, age and procedure. Rev Esp Enferm Dig. 95:863–875.

9. Cohen CD, Keuneke C, Schiemann U, et al. 2001; Hyponatraemia as a complication of colonoscopy. Lancet. 357:282–283. DOI: 10.1016/S0140-6736(00)03619-9.

10. Erasmus RT, Matsha TE. 1998; The frequency, aetiology and outcome of severe hyponatraemia in adult hospitalised patients. Cent Afr J Med. 44:154–158.

11. Hawkins RC. 2003; Age and gender as risk factors for hyponatremia and hypernatremia. Clin Chim Acta. 337:169–172. DOI: 10.1016/j.cccn.2003.08.001. PMID: 14568195.

12. Belsey J, Epstein O, Heresbach D. 2009; Systematic review: adverse event reports for oral sodium phosphate and polyethylene glycol. Aliment Pharmacol Ther. 29:15–28. DOI: 10.1111/j.1365-2036.2008.03837.x. PMID: 18729847.

13. Choi KS, Lee YM, Jung SW, et al. 2005; Three cases of hyponatremia caused by ingestion of bowel preparation solution for colonoscopy. Korean J Nephrol. 24:295–299.

14. Ko SH, Lim CH, Kim JY, Kang SH, Baeg MK, Oh HJ. 2014; Case of inappropriate ADH syndrome: hyponatremia due to polyethylene glycol bowel preparation. World J Gastroenterol. 20:12350–12354. DOI: 10.3748/wjg.v20.i34.12350. PMID: 25232272. PMCID: PMC4161823.

15. Kwon KH, Lee JA, Lim YJ, et al. 2020; A prospective randomized clinical study evaluating the efficacy and compliance of oral sulfate solution and 2-L ascorbic acid plus polyethylene glycol. Korean J Intern Med. 35:873–880. DOI: 10.3904/kjim.2017.275. PMID: 30685963. PMCID: PMC7373964.

16. Spadaccini M, Frazzoni L, Vanella G, et al. 2020; Efficacy and tolerability of high- vs low-volume split-dose bowel cleansing regimens for colonoscopy: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 18:1454–1465.e14. DOI: 10.1016/j.cgh.2019.10.044. PMID: 31683057.

17. Kwak MS, Cha JM, Yang HJ, et al. 2019; Safety and efficacy of low-volume preparation in the elderly: oral sulfate solution on the day before and split-dose regimens (SEE SAFE) study. Gut Liver. 13:176–182. DOI: 10.5009/gnl18214. PMID: 30400725. PMCID: PMC6430430.

18. Pelham RW, Alcorn H Jr, Cleveland Mv. 2010; A pharmacokinetics evaluation of a new, low-volume, oral sulfate colon cleansing preparation in patients with renal or hepatic impairment and healthy volunteers. J Clin Pharmacol. 50:350–354. DOI: 10.1177/0091270009339741. PMID: 20067942.

19. Di Palma JA, Bhandari R, Cleveland MV, et al. 2021; A safety and efficacy comparison of a new sulfate-based tablet bowel preparation versus a PEG and ascorbate comparator in adult subjects undergoing colonoscopy. Am J Gastroenterol. 116:319–328. DOI: 10.14309/ajg.0000000000001020. PMID: 33165006. PMCID: PMC7864663.

20. Ayus JC, Varon J, Arieff AI. 2000; Hyponatremia, cerebral edema, and noncardiogenic pulmonary edema in marathon runners. Ann Intern Med. 132:711–714. DOI: 10.7326/0003-4819-132-9-200005020-00005. PMID: 10787364.